Cystinosis, Nephropathic; Ctns
Description
Cystinosis has been classified as a lysosomal storage disorder on the basis of cytologic and other evidence pointing to the intralysosomal localization of stored cystine. Cystinosis differs from the other lysosomal diseases inasmuch as acid hydrolysis, the principal enzyme function of lysosomes, is not known to play a role in the metabolic disposition of cystine. The fact that plasma levels are well below saturation indicates that the defect is a cellular one. Within the cell, cystine is compartmentalized with acid phosphatase and is membrane-bound as demonstrated by electron microscopy. Ferritin accumulates in the same organelle which appears to be the lysosome.
Clinical Features
Top most frequent phenotypes and symptoms related to Cystinosis, Nephropathic; Ctns
- Short stature
- Growth delay
- Muscle weakness
- Cognitive impairment
- Hepatomegaly
- Fever
- Skeletal muscle atrophy
- Frontal bossing
- Dysphagia
- Blindness
And another 55 symptoms. If you need more information about this disease we can help you.
Incidence and onset information
— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)— The onset for some of the known clinical features related to this disease may vary, including adult onset, adult onset, adult onset, infantile onset, infantile onset, infantile onset, infantile onset, infantile onset, juvenile onset, juvenile onset, young adult onset, young adult onset, young adult onset, and childhood onset .
Alternative names
Cystinosis, Nephropathic; Ctns Is also known as cystinosin, defect of, lysosomal cystine transport protein, defect of.
Researches and researchers
Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.Cystinosis, Nephropathic; Ctns Recommended genes panels
Panel Name, Specifity and genes Tested/covered |
---|
GeneAware Complete Panel Version 2 (Female).
By Baylor Miraca Genetics Laboratories (United States).
RMRP, BCS1L, SACS, BLM, SGCA, SGCB, SGCG, SGSH, SLC12A6, SLC17A5, SLC22A5, SLC25A13, SLC25A15, SLC26A2, SLC35A3, SLC7A7, SMN1, SMPD1, BTD, BTK , (...)
View the complete list with 139 more genes
Specificity
1 %
Genes
100 % |
GeneAware Complete Panel Version 2 (Male).
By Baylor Miraca Genetics Laboratories (United States).
RMRP, BCS1L, SACS, BLM, SGCA, SGCB, SGCG, SGSH, SLC12A6, SLC17A5, SLC22A5, SLC25A13, SLC25A15, SLC26A2, SLC35A3, SLC7A7, SMN1, SMPD1, BTD, TGM1 , (...)
View the complete list with 129 more genes
Specificity
1 %
Genes
100 % |
Lysosomal Storage Disease Panel.
By Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center (United States).
SGSH, SLC17A5, SMPD1, TCF4, MCOLN1, NPC2, ADAMTSL2, DNAJC5, SUMF1, TPP1, CLN3, CLN5, CLN6, CLN8, DYM, ANTXR2, COL11A2, PEX26, GNE, CTNS , (...)
View the complete list with 54 more genes
Specificity
2 %
Genes
100 % |
CTNS Sequence analysis and 57 kb deletion analysis.
By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center (United States).
CTNS
Specificity
100 %
Genes
100 % |
Lysosomal Storage Disease Panel.
By Molecular Genetics Laboratory Centro de Investigaciones Endocrinologicas "Dr. Cesar Bergada" (Argentina).
SGSH, SLC17A5, SMPD1, MCOLN1, NPC2, DNAJC5, SUMF1, TPP1, CLN3, CLN5, CLN6, CLN8, GNPTG, CTNS, CTSD, CTSK, HGSNAT, MFSD8, GNPTAB, AGA , (...)
View the complete list with 30 more genes
Specificity
2 %
Genes
100 % |
ExomePLUS Electrolyte & Kidney Stone.
By Laboratory for Molecular Medicine Partners HealthCare Personalized Medicine (United States).
SCNN1A, SCNN1B, SLC12A1, SLC12A3, SLC2A2, VDR, WNK4, CASR, BSND, CDC73, SLC22A12, CLCN5, CLCNKB, SLC34A3, CLDN16, CLDN19, FAM20C, FAM20A, HOGA1, CTNS , (...)
View the complete list with 28 more genes
Specificity
3 %
Genes
100 % |
CTNS. Detection of the mutations p.Trp138X, p.Thr7Phe, p.Gln128X, p.Trp182Arg, p.Leu158Pro, p.Gly308Arg, p.Asp205del and p.Ile133Proby sequencing.
By Instituto de Medicina Genomica Instituto de Medicina Genomica (Spain).
CTNS
Specificity
100 %
Genes
100 % |
CTNS. Detection of the deletion 57Kb (exons 1 to 10) by microsatellite analysis.
By Instituto de Medicina Genomica Instituto de Medicina Genomica (Spain).
CTNS
Specificity
100 %
Genes
100 % |
You can get up to 42 more panels with our dedicated tool
Learn moreSources and references
You can check the following sources for additional information.
OMIM Rare Disease Symptoms CheckerIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like MYOFIBROMATOSIS, INFANTILE, 2; IMF2 TOOTH AGENESIS, SELECTIVE, 1; STHAG1 MACS SYNDROME